or Try an Advanced Search...

    Spondylitis Stocks List

    Symbol Grade Name % Change
    MLTX B MoonLake Immunotherapeutics 4.74
    ABBV D AbbVie Inc. 3.04
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Autoimmune Disease Psoriatic Arthritis Adalimumab Advanced Prostate Cancer Anemia Arthritis Atopic Dermatitis Biopharmaceutical Blood Cancers Chronic Idiopathic Constipation Clinical Medicine Combination Drugs Constipation Crohn's Disease Depressive Disorder Endometriosis Eye Care Products Genotype Hematological Malignancies Hepatitis C

    Related ETFs - A few ETFs which own one or more of the above listed Spondylitis stocks.

    Symbol Grade Name Weight
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    BOTZ B Global X Robotics & Artificial Intelligence Thematic ETF 9.31
    MEDX F Horizon Kinetics Medical ETF 7.81
    GRID C First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund 7.75
    FDL A First Trust Morningstar ETF 6.79
    View all Spondylitis ETFs...
    Compare ETFs
    Compare HDLB to BOTZ Compare HDLB to FDL Compare HDLB to MEDX

        Spondylitis Stocks Recent News

        Date Stock Title
        Nov 22 ABBV AbbVie gains on Leerink Partners upgrade to Outperform
        Nov 22 ABBV AbbVie: Upgrading To 'Strong Buy' After Pullback
        Nov 22 ABBV J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
        Nov 22 ABBV AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
        Nov 22 ABBV AbbVie upgraded to outperform by Leerink on recent sell-off
        Nov 21 MLTX MoonLake Immunotherapeutics: A Somewhat Complicated Story
        Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
        Nov 19 ABBV Where Will AbbVie Be in 5 Years?
        Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
        Nov 19 ABBV RVPH: Year-End OLE Update
        Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
        Nov 18 ABBV AbbVie snaps eight straight sessions of losses
        Nov 18 ABBV Aldeyra announces FDA acceptance of resubmitted reproxalap application
        Nov 18 ABBV AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe
        Nov 18 ABBV Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan Aesthetics Products
        Nov 18 ABBV AbbVie’s Elahere wins European approval for certain ovarian cancers
        Nov 18 ABBV Why This Beaten-Down Dividend Stock Is a No-Brainer Buy on the Dip
        Nov 18 ABBV AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer
        Nov 17 ABBV Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
        Nov 17 ABBV AbbVie's (NYSE:ABBV) Shareholders Will Receive A Bigger Dividend Than Last Year
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Autoimmune Disease Psoriatic Arthritis Adalimumab Advanced Prostate Cancer Anemia Arthritis Atopic Dermatitis Biopharmaceutical Blood Cancers Chronic Idiopathic Constipation Clinical Medicine Combination Drugs Constipation Crohn's Disease Depressive Disorder Endometriosis Eye Care Products Genotype Hematological Malignancies Hepatitis C
        Spondylitis

        Spondylitis is an inflammation of the vertebrae. It is a form of spondylopathy. In many cases, spondylitis involves one or more vertebral joints, as well, which itself is called spondylarthritis.

        More about Spondylitis
        Browse All Tags